Table 1 Participant characteristic summary table per study arm.
Participant characteristics | Placebo (48 men) | Atorvastatin (55 men) |
|---|---|---|
Age, median (IQR) | 64.5 (10) | 65 (9) |
BMI, median, (IQR) | 26.6 (4.1) | 26.4 (4.9) |
Smoking, n (%) | 8 (17) | 13 (23.6) |
Hypertension, n (%) | 16 (34) | 21 (38.2) |
Diabetes mellitus, n (%) | 6 (12.8) | 4 (7.3) |
Intervention duration, median (range) | 27 (13–76) | 28 (10–114) |
Pathological Gleason grade, n (%) | ||
ISUP Gleason grade ≤ 2 | 37 (78.7) | 42 (76.3) |
ISUP Gleason grade ≥ 3 | 10 (21.2) | 13 (23.6) |
Pathological T-stage, n (%) | ||
T2b or lower | 1 (2.1) | 5 (9.0) |
T2c or higher | 46 (97.9) | 50 (91) |
